|
About the e-drug category
|
|
0
|
72
|
June 19, 2023
|
|
Invitation and call for abstracts: 3rd Virtual Pharmaceutical Policy Symposium 23-24 June 2026
|
|
0
|
15
|
January 20, 2026
|
|
Learn about Traceability of Medical Products in a Peer Learning format! Free Programs starts from 2nd February.
|
|
0
|
15
|
January 15, 2026
|
|
Pharma package: EU seals deal on overhaul of two-decade-old medicines law
|
|
0
|
19
|
December 18, 2025
|
|
EU Clinches Landmark Pharma Reform, but Industry Cites Threat to Competitiveness
|
|
0
|
20
|
December 18, 2025
|
|
Deepening Accountability: The Fair Pharma Scorecard and Access to Medicines in a Fragmented Global Health Law Landscape
|
|
0
|
34
|
December 12, 2025
|
|
WHO expert group’s new analysis reaffirms there is no link between vaccines and autism
|
|
0
|
10
|
December 11, 2025
|
|
Access to Medicines in Tajikistan
|
|
0
|
19
|
December 9, 2025
|
|
Access to EMs for NCDs during conflicts: cardiovascular diseases, diabetes and epilepsy in Northern Syria
|
|
0
|
26
|
December 8, 2025
|
|
WHO says weight loss drugs are 'new chapter' in fight against obesity
|
|
0
|
8
|
December 3, 2025
|
|
UNIGE NCD Policy Lab: Sources of insulin, oral medicines, and medical devices for diabetes for low-and middle income countries
|
|
0
|
14
|
December 2, 2025
|
|
Prequalifying the Qualified: The Lenacapavir Paradox
|
|
5
|
94
|
November 25, 2025
|
|
BMJ collection on Novel Medicines (costly new medicines)
|
|
0
|
13
|
November 13, 2025
|
|
Call for Abstracts - ISIUM Conference November 2026 - Nepal
|
|
0
|
25
|
November 13, 2025
|
|
Publication: time to inclusion of medicines in National Essential Medicines Lists compared to the WHO Model List
|
|
0
|
13
|
November 6, 2025
|
|
Publication: Assessing the Impact of Antimicrobial Resistance Awareness Interventions Among Schoolchildren in Bangladesh
|
|
0
|
16
|
October 19, 2025
|
|
Contextual constraints and dilemmas influencing health providers’ prescription practices in a conflict-affected area
|
|
0
|
31
|
October 18, 2025
|
|
Publication: Human Antimicrobial Use in Bangladesh: Five-Year Trend Analysis Including COVID-19 Pandemic Era
|
|
0
|
9
|
October 16, 2025
|
|
Publication: Access to Medical Products in the WHO South-East Asia Region 2025
|
|
0
|
21
|
October 15, 2025
|
|
WHO releases new reports on new tests and treatments in development for bacterial infections
|
|
0
|
28
|
October 13, 2025
|
|
generic risdiplam for SMA in India
|
|
0
|
9
|
October 10, 2025
|
|
First lenacapavirs prequalified
|
|
0
|
22
|
October 10, 2025
|
|
Pharma shift away from infectious disease could spell disaster for the world poorest people
|
|
0
|
21
|
October 10, 2025
|
|
Assessing the performance of local pharmaceutical systems: An analytical approach to improve access to medicine
|
|
0
|
28
|
October 5, 2025
|
|
Country preparedness for the introduction and appropriate use of antibiotics: operational guidance
|
|
0
|
16
|
October 3, 2025
|
|
List of National Regulatory Authorities (NRAs) operating at maturity level 3 (ML3) and maturity level 4 (ML4)
|
|
0
|
28
|
October 3, 2025
|
|
Country preparedness for the introduction and appropriate use of antibiotics: operational guidance
|
|
0
|
23
|
October 3, 2025
|
|
Availability of essential medicines in 14 remaining health facilities in Gaza
|
|
0
|
28
|
October 1, 2025
|
|
WHO Global Forum for Public Procurement of Health Products
|
|
0
|
42
|
September 20, 2025
|
|
Dispensing of medicines for asthma and COPD through the government health insurance in Syria
|
|
0
|
36
|
September 13, 2025
|